{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:lucorafusp alfa [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:tixestobart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:benufutamab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:invikafusp alfa [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:imeroprubart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00907504: Phase 3 Interventional Withdrawn Carcinoma, Non-Small-Cell Lung
(2010)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:talovirtide [INN]
Source URL:
Class:
PROTEIN